Kyverna Therapeutics, Inc.

KYTX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.5B · 130 employees
49
SEC Filings
$7.9
Close 2026-06-02
130
Employees

Business Summary

1 Item 1A. Risk Factors 44 Item 1B. Unresolved Staff Comments 119 Item 1C. Cybersecurity 119 Item 2. Properties 120 Item 3. Legal Proceedings 120 Item 4. Mine Safety Disclosures 121 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 122 Item 6. [Reserved] 123 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 124 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 13...

Latest Stock Quote

KYTX 2026-06-02 $7.9 O:$8.2 H:$8.2 L:$7.57 Vol:1.6M VWAP:$7.7828
origin leaf: 9de62b0acbbeb9f8d1ae22e7afbe45aef81533ce2a4e7a15a06c48a25e141bfc

Next Earnings

Q2 FY2026 — expected 2026-09-18

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001193125-26-126242EDGAR130K words
2025-03-272024-12-310000950170-25-046074EDGAR—
2024-03-262023-12-310000950170-24-036481EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-277584EDGAR80K words
2025-08-122025-06-300000950170-25-107321EDGAR—
2025-05-132025-03-310000950170-25-070325EDGAR—
2024-11-132024-09-300000950170-24-126366EDGAR—
2024-08-122024-06-300000950170-24-095462EDGAR—
2024-05-142024-03-310000950170-24-059628EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001193125-26-126216EDGAR3K words
2026-02-240001193125-26-065320EDGAR—
2026-02-030001193125-26-034464EDGAR—
2026-01-120001193125-26-009810EDGAR—
2025-12-180001213900-25-123033EDGAR—
2025-12-150001193125-25-318469EDGAR—
2025-12-150001193125-25-318377EDGAR—
2025-11-120001193125-25-277569EDGAR—
2025-11-030001193125-25-261719EDGAR—
2025-10-290001193125-25-254698EDGAR—

49 total filings indexed. 30 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001994702
TickerKYTX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.kyvernatx.com
Listed2024-02-08

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: bb35f78565f2e56c3aa1fceb28977a715a22459774909f1ae1412bfd215d296f
parent: de2c584d9e8ae37209b7c5032d1b69eeca50adec332f1281f2eb9b976d784b3f
content hash: 1c21563fd99d77430090dcc85c986b9951cc5897ad7d47f026fae09b8601eecd
signed: 2026-06-03T12:01:39.524Z
sources: 10 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf